A Comparison of Methods for the Measurement of Activated Factor VII

Summary

A number of different methods are available for the measurement of factor VIIa. Almost all of these employ ratios of two different measurements of factor VII. In order to determine which is the most sensitive to activated factor VII we have compared currently available methods in the following groups: two patients with haemophilia A following treatment with activated recombinant factor VII (rVII a); 6 normal plasmas during cold promoted activation of factor VII; normal individuals (n = 23); and patients with unequivocal disseminated intravascular coagulation (DIC, n = 19). Factor VII was measured in an amidolytic assay (VII: Amid) and an antigen assay (VII:Ag). Clotting activity was measured using rabbit (VII:C Rab), human (VII:C Hum) and bovine (VII:C Bov) thromboplastin.

Of the clotting assays the most sensitive to the presence of factor VIIa was that which utilised bovine thromboplastin. Amidolytic and immunological measurements were unaffected by the activity state of factor VII. The ratios VII:C Rab/VII: Ag and VII:C Rab/VII:Amid were insensitive to activated factor VII. The ratios most sensitive to the presence of factor VII a were VII:C Bov/VII: Amid and VII: C Bov/VII:Ag. The ratios VII:C Bov/VII:C Rab and VII:C Bov/VII:C Hum are less sensitive but have the advantage for epidemiological studies of narrower reference ranges.

• References

• 1 Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 1: 1050-1054
• 2 Meade TW, Mellows S, Brozovich M, Miller GJ, Chakrabarti R, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease; principle results of the Northwick Park heart study. Lancet 1986; 2: 533-537
• 3 Broze GJ. Marjerus PW Purification and properties of human factor VII. J Biol Chem 1980; 255: 1242-1247
• 4 Bajaj SP, Rapaport SI, Brown SF. Isolation and characterisation of human factor VII. J Biol Chem 1981; 256: 253-259
• 5 Nemerson Y. Regulation and initiation of coagulation by factor VII. Haemostasis 1983; 13: 150-155
• 6 Østerud B. How to measure factor VII and factor VII activation. Haemostasis 1983; 13: 161-168
• 7 Rao LVM, Rapaport SI. Factor VIIa catalysed activation of factor X independent of tissue factor; its possible significance for control of haemophilic bleeding by infused factor VIIa. Blood 1990; 75: 1069-1073
• 8 Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD. Factor IX is activated in vivo by the tissue factor mechanism. Blood 1990; 76: 731-736
• 9 Pelzer H, Scharz A, Stuber W. Quantitative immunochemical determination of human factor VIIa in plasma with an antibody against a synthetic peptide. Thromb Haemostas 1991; 65: 906
• 10 Hemker HC, Muller AD, Gonggrijp R. The estimation of activated human blood coagulation factor VII. J Mol Med 1976; 1: 127-134
• 11 Van Deijk WA, Dam-Mieras MCE, Muller AD, Hemker HC. Evaluation of a coagulation assay determining the activity state of factor VII in plasma. Haemostasis 1983; 13: 192-197
• 12 Kitchen S, Malia RG, Greaves M, Preston FE. A method for the determination of activated factor VII using bovine and rabbit brain thromboplastin; demonstration of increased levels in disseminated intravascular coagulation. Thromb Res 1988; 50: 191-200
• 13 Seligsohn U, Østerud B, Rapaport SI. Coupled amidolytic assay for factor VII: Its use with clotting assay to determine the activity state of factor VII. Blood 1978; 52: 978-988
• 14 Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP, Meade TW. Assay of factor VII activity by two techniques; evidence for increased conversion of VII to VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985; 59: 249-258
• 15 Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischaemic heart disease. J Am Coll Cardiol 1989; 14: 941-946
• 16 Carvalho de Sousa J, Azevedo J, Soria C, Barros F, Ribeiro C, Parreira F, Caen JP. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. Thromb Res 1988; 51: 165-173
• 17 Gjonnaess H. Cold promoted activation of factor VII. – IV. Relation to the coagulation system. Thromb Diathes Haemorrh 1972; 28: 194-205
• 18 Boyer C, Wolf M, Rothschild C, Migaud M, Amiral J, Mannucci PM, Meyer D, Larrieu MJ. An enzyme linked immunoassay (ELISA) for the quantitation of human factor VII. Thromb Haemostas 1986; 56: 250-255
• 19 Fuller JH, Keen H, Jarrett RJ, Omer T, Meade TW, Chakrabarti R, North WRS, Stirling Y. Haemostatic variables associated with diabetes and its complications. Br Med J 1979; 2: 964-966
• 20 Ford I, Singh TP, Kitchen S, Makris M, Ward JD, Preston FE. Activation of coagulation in relation to the presence of vascular complications. Diabetic Med 1991; 8: 322-329
• 21 Dalaker K. Clotting factor VII during pregnancy, delivery and puerperium. Br J Gynaecol 1986; 93: 17-23
• 22 Brozovich M, Stirling Y, Harricks C, North WRS, Meade TW. Factor VII in an industrial population. Br J Haematol 1974; 28: 381-391
• 23 Scarabin PY, Van Dreden P, Bonithon-Kop C, Orssaud G, Bara L, Conard J, Samama M. Age related changes in factor VII activation in healthy women. Clin Sci 1988; 75: 341-343
• 24 Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Truffert J, Mirashi MC, de Gennes JL, Caen JP. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidaemia: a clinical and laboratory study. Haemostasis 1989; 19: 83-90
• 25 Warr TA, Rao LV, Rapaport SI. Disseminated Intravascular Coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma EPI activity. Blood 1990; 75: 1481-1489